LG Life Science LTD. - Product Pipeline Review - 2016

  • ID: 3960489
  • Company Profile
  • 71 pages
  • Global Markets Direct
1 of 5
LG Life Science LTD. - Product Pipeline Review - 2016

The report ‘LG Life Science LTD. - Product Pipeline Review - 2016’, provides an overview of the LG Life Science LTD.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by LG Life Science LTD., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of LG Life Science LTD.
- The report provides overview of LG Life Science LTD. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses LG Life Science LTD.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features LG Life Science LTD.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate LG Life Science LTD.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for LG Life Science LTD.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding LG Life Science LTD.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Introduction

LG Life Science LTD. Snapshot

LG Life Science LTD. Overview

Key Facts

LG Life Science LTD. - Research and Development Overview

Key Therapeutic Areas

LG Life Science LTD. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

LG Life Science LTD. - Pipeline Products Glance

LG Life Science LTD. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

LG Life Science LTD. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

LG Life Science LTD. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

LG Life Science LTD. - Unknown Stage Pipeline Products

Unknown Products/Combination Treatment Modalities

LG Life Science LTD. - Drug Profiles

(gemigliptin + glimepiride) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(gemigliptin + metformin hydrochloride) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(gemigliptin + rosuvastatin calcium) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(lercanidipine hydrochloride + valsartan) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

adalimumab biosimilar - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

etanercept biosimilar - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Eupenta - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

exenatide SR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

infliximab biosimilar - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

interferon alfa-2a SR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LBDE - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LBVC - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LBVD - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LBVE-013 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LBVE-014 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-231306 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-280126 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-280391 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-34AD3 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-350189 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-541239 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LC-65AOD3 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LD-02GIFRO - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Monoclonal Antibody to Inhibit VEGF for Cancer - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NecX - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

nivocasan - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rituximab biosimilar - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Inhibit PAR-1 for Atherothrombosis - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Obesity - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit 20S Proteasome for Multiple Myeloma and Solid Tumor - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

somatropin - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

somatropin SR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LG Life Science LTD. - Pipeline Analysis

LG Life Science LTD. - Pipeline Products by Target

LG Life Science LTD. - Pipeline Products by Route of Administration

LG Life Science LTD. - Pipeline Products by Molecule Type

LG Life Science LTD. - Pipeline Products by Mechanism of Action

LG Life Science LTD. - Dormant Projects

LG Life Science LTD. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

LG Life Science LTD., Key Facts

LG Life Science LTD. - Pipeline by Indication, 2016

LG Life Science LTD. - Pipeline by Stage of Development, 2016

LG Life Science LTD. - Monotherapy Products in Pipeline, 2016

LG Life Science LTD. - Combination Treatment Modalities in Pipeline, 2016

LG Life Science LTD. - Partnered Products in Pipeline, 2016

LG Life Science LTD. - Partnered Products/ Combination Treatment Modalities, 2016

LG Life Science LTD. - Out-Licensed Products in Pipeline, 2016

LG Life Science LTD. - Out-Licensed Products/ Combination Treatment Modalities, 2016

LG Life Science LTD. - Pre-Registration, 2016

LG Life Science LTD. - Phase III, 2016

LG Life Science LTD. - Phase II, 2016

LG Life Science LTD. - Phase I, 2016

LG Life Science LTD. - Preclinical, 2016

LG Life Science LTD. - Discovery, 2016

LG Life Science LTD. - Unknown, 2016

LG Life Science LTD. - Pipeline by Target, 2016

LG Life Science LTD. - Pipeline by Route of Administration, 2016

LG Life Science LTD. - Pipeline by Molecule Type, 2016

LG Life Science LTD. - Pipeline Products by Mechanism of Action, 2016

LG Life Science LTD. - Dormant Developmental Projects,2016

LG Life Science LTD., Other Locations

LG Life Science LTD., Subsidiaries

List of Figures

LG Life Science LTD. - Pipeline by Top 10 Indication, 2016

LG Life Science LTD. - Pipeline by Stage of Development, 2016

LG Life Science LTD. - Monotherapy Products in Pipeline, 2016

LG Life Science LTD. - Combination Treatment Modalities in Pipeline, 2016

LG Life Science LTD. - Out-Licensed Products in Pipeline, 2016

LG Life Science LTD. - Pipeline by Top 10 Target, 2016

LG Life Science LTD. - Pipeline by Route of Administration, 2016

LG Life Science LTD. - Pipeline by Molecule Type, 2016

LG Life Science LTD. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- eFFECTOR Therapeutics, Inc.
- Ionis Pharmaceuticals, Inc.
- Onconova Therapeutics, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll